
Eleonora Teplinsky, MD, is the head of breast and gynecologic medical oncology and Valley-Mount Sinai Comprehensive Cancer Center in Paramus, New Jersey, as well as an ASCO breast cancer expert. She explained the most compelling research results on breast cancer presented at the 2026 American Society of Clinical Oncology Annual Meeting. Listen to the episode to hear Dr. Teplinsky explain: the importance of the OPTIMA study, as well as her caveats about the results the latest results from the ASCENT-04 study what progression-free survival 2 (PFS2) is and how it helps doctors decide which treatments should be given first what we do and don’t know about GLP-1 medicines and cancer
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

ASCO 2026 Poster Session Research

Creating More Equitable Health Systems

Losing Weight Boosts Quality of Life in Early-Stage Breast Cancer

Does Breast Cancer That Seems to Have High Recurrence Risk Always Need Chemo?
Free AI-powered recaps of Breastcancer.org Podcast and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.